2020
DOI: 10.5114/reum.2020.93511
|View full text |Cite
|
Sign up to set email alerts
|

The place of omega-3 and omega-6 acids in supplementary treatment of inflammatory joint diseases

Abstract: Eating habits have been analysed for years as a factor influencing the development of autoimmune diseases and susceptibility to infections. On the basis of research, observational studies and metaanalyses, special attention was paid to omega-3 and omega-6 acids. The purpose of the review is to show the importance of omega-3 and omega-6 acids as important ingredients in the healthy diet and as factors protecting against the development of the most common inflammatory rheumatic diseases. The influence of these o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 57 publications
(56 reference statements)
0
3
0
Order By: Relevance
“…Both, EPA and DHA supplementation was discovered to increase membrane fluidity and lipid raft clustering leading to Other important PUFAs involved in inflammation and allergy are the ω-3 acids eicosapentaenoic acid (EPA, 20:5) and docosahexaenoic acid (DHA, 22:6) (Figure 2). The supplementation of these ω-3 acids with diet was previously associated with favorable outcomes in a variety of disease models [147][148][149][150][151]. Both, EPA and DHA supplementation was discovered to increase membrane fluidity and lipid raft clustering leading to decreased cell activation [152].…”
Section: Phospholipase a 2 Cleavage Products: Free Fatty Acidsmentioning
confidence: 99%
“…Both, EPA and DHA supplementation was discovered to increase membrane fluidity and lipid raft clustering leading to Other important PUFAs involved in inflammation and allergy are the ω-3 acids eicosapentaenoic acid (EPA, 20:5) and docosahexaenoic acid (DHA, 22:6) (Figure 2). The supplementation of these ω-3 acids with diet was previously associated with favorable outcomes in a variety of disease models [147][148][149][150][151]. Both, EPA and DHA supplementation was discovered to increase membrane fluidity and lipid raft clustering leading to decreased cell activation [152].…”
Section: Phospholipase a 2 Cleavage Products: Free Fatty Acidsmentioning
confidence: 99%
“…The ratio of ω-3 to ω-6 PUFAs in vivo may be determined by the individual’s inflammatory status 27 , 28 . Derivatives of EPA, which is an ω-6 PUFA, are predominantly proinflammatory (prostaglandin-E2, thromboxane-A2, and leukotriene-B4), whereas metabolism of long-chain ω-3 PUFAs produces anti-inflammatory eicosanoids (e.g., resolvins and protectins), which can inhibit the production of proinflammatory mediators such as interleukin-1 (IL-1) and tumor necrosis factor (TNF-α) 29 , 30 . These mechanisms have been linked to ocular surface damage and tear film quality in individuals with DES.…”
Section: Introductionmentioning
confidence: 99%
“…It seems that the role of omega-3 acids has been proven [40]. The Mediterranean diet is a widely recognized beneficial pattern of nutrition in inflammatory diseases, including RA [41,42]. Apart from omega-3 acids, the immunomodulatory effect of fiber has been demonstrated [38].…”
Section: Rheumatoid Arthritismentioning
confidence: 99%